Moderna, Inc.

MRNA

161
'Ticker: MRNA

Direction: Up

Prognosis: Buy Calls (Author bought $40 and $41 calls expiring this week, considering rolling to later dates)

Reasoning: New Covid-like virus discovered, rising avian flu concerns, large institutional buying, bullish technical indicators (RSI divergence, MACD turning up), high call option volume and open interest. Author acknowledges that a drop below $30 could invalidate the thesis.

Disclaimer: This is not financial advice. MRNA is volatile; know your risk tolerance.

Bonus: Author also mentions potential plays on HD puts, LOW puts, and CLF calls.'

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.